Patel Chintu
SEC insider (Form 3/4/5 filer). CIK 0001737428. Co-CEO at Amneal Pharmaceuticals, Inc. (AMRX). 16 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in BRIDGEWATER, NJ.
Companies Patel Chintu has filed insider reports for
- Amneal Pharmaceuticals, Inc. (AMRX): Director, Officer, Co-CEO
Patel Chintu
CIK: 0001737428
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Amneal Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Aug 10, 2026AMRX
Amneal Pharmaceuticals, Inc.
AwardIndirect6.4M shares- - Mar 4, 2026AMRX
Amneal Pharmaceuticals, Inc.
ExerciseDirect92.6K shares- - Mar 4, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax PaymentDirect29K shares at avg. $13.30$385K - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax PaymentDirect17.1K shares at avg. $13.31$228K - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax PaymentDirect315.9K shares at avg. $13.31$4.2M - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
ExerciseDirect59.9K shares- - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
ExerciseDirect733.9K shares- - Mar 2, 2026AMRX
Amneal Pharmaceuticals, Inc.
AwardDirectPerformance-Based Restricted Stock Units
544.7K shares- - Mar 2, 2026AMRX
Amneal Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
190.6K shares- - Mar 2, 2026AMRX
Amneal Pharmaceuticals, Inc.
AwardDirectPerformance-Based Restricted Stock Units
354K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Award | 6,381,734 | - | $0 | Indirect |
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise | 92,593 | - | $0 | Direct |
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment | 28,983 | $13.30 | $385,474 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment | 17,112 | $13.31 | $227,761 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment | 315,885 | $13.31 | $4,204,429 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise | 59,931 | - | $0 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise | 733,944 | - | $0 | Direct |
| Mar 2, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Award Performance-Based Restricted Stock Units | 544,663 | - | - | Direct |
| Mar 2, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Award Restricted Stock Units | 190,632 | - | - | Direct |
| Mar 2, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Award Performance-Based Restricted Stock Units | 354,031 | - | - | Direct |
1-10 of 16 transactions